EMSIVEL
LIVE

Serial Number

79228887

Owner

NOVARTIS AG

Filing Date

Jan 31, 2018

Add to watchlist:

No watchlists yet
View on USPTO

EMSIVEL Trademark

Serial Number: 79228887 • Registration: 5548052

EMSIVEL is a trademark filed by NOVARTIS AG on January 31, 2018. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

NOVARTIS AG (7,166 trademarks)

CH-4002
BASEL , CH

Entity Type: 03

Trademark Details

Filing Date

January 31, 2018

Registration Date

August 28, 2018

Published for Opposition

June 12, 2018

Cancellation Date

November 10, 2021

Goods & Services

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for ophthalmological use; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and the treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma, * excluding mineral salts or products containing mineral salts and excluding products for the prevention and treatment or respiratory disorders and diseases *

Filing History

NOTIFICATION PROCESSED BY IB
Sep 19, 2022 GPNX
NOTIFICATION PROCESSED BY IB
Mar 21, 2022 GPNX
NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED
Nov 28, 2021 DENC
DEATH OF INTERNATIONAL REGISTRATION
Nov 28, 2021 DETH
INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
Oct 4, 2019 INNA
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
Sep 17, 2019 INPR
CORRECTION UNDER SECTION 7 - PROCESSED
Jan 17, 2019 COC.
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Jan 17, 2019 APRE
LIMITATION FROM THE IB EXAMINED AND ENTERED
Jan 17, 2019 LIME
LIMITATION OF GOODS RECEIVED FROM IB
Jan 10, 2019 LIMG
NOTIFICATION PROCESSED BY IB
Oct 19, 2018 GPNX
FINAL DISPOSITION NOTICE SENT TO IB
Oct 2, 2018 FICS
FINAL DISPOSITION PROCESSED
Oct 2, 2018 FIMP
GRANT OF PROTECTION CREATED, TO BE SENT TO IB
Sep 27, 2018 GPAR
REGISTERED-PRINCIPAL REGISTER
Aug 28, 2018 R.PR
PUBLISHED FOR OPPOSITION
Jun 12, 2018 PUBO
NOTIFICATION PROCESSED BY IB
Jun 8, 2018 GPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
May 23, 2018 OPNS
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
May 23, 2018 OP2R
NOTICE OF PUBLICATION
May 23, 2018 NPUB
APPROVED FOR PUB - PRINCIPAL REGISTER
May 10, 2018 CNSA
ASSIGNED TO EXAMINER
Apr 27, 2018 DOCK
APPLICATION FILING RECEIPT MAILED
Mar 31, 2018 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 27, 2018 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Mar 23, 2018 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Mar 22, 2018 REPR